- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04507542
Enriched Music-Supported Therapy to Restore Motor Deficits After Stroke (HOMEMUSIC)
August 7, 2020 updated by: Antoni Rodriguez Fornells, University of Barcelona
Playing and Singing for the Recovering Brain: Efficacy of Enriched Social-Motivational Musical Interventions in Stroke Rehabilitation
Music-Supported Therapy (MST) is a rehabilitation technique to improve the upper extremity motor function of stroke patients through playing musical instruments.
A modified version of the MST protocol has been created (hereafter, referred as enriched MST, eMST) to include (i) a home-based self-training program using an app for electronic tablets and (ii) weekly group sessions of musical playing strengthening the motivational and emotional components of music playing.
A randomised controlled trial will be conducted to test the effectiveness of this enriched MST (eMST) protocol in improving motor functions, cognition, emotional well-being and quality of life when compared to a program of home-based exercises utilizing the Graded Repetitive Arm Supplementary Program (GRASP).
Sixty stroke patients will be recruited and randomly allocated to an eMST group (n=30) or a control GRASP intervention group (n=30).
Patients will be evaluated before and after a 10-week intervention, as well as at 3-month follow-up.
The primary outcome of the study is the functionality of the paretic upper limb measured with the Action Research Arm Test.
Secondary outcomes include other motor and cognitive functions, emotional well-being and quality of life measures as well as self-regulation and self-efficacy outcomes.
We hypothesize that patients treated with eMST will show larger improvements in their motor and cognitive functions, emotional well-being and quality of life than patients treated with a home-based GRASP intervention.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Antoni Rodríguez Fornells, PhD
- Phone Number: +34934020489
- Email: antoni.rodriguez@icrea.cat
Study Contact Backup
- Name: Jennifer Grau Sánchez, PhD
- Phone Number: +34934020489
- Email: jennifergrau@euit.fdsll.cat
Study Locations
-
-
Barcelona
-
L'Hospitalet De Llobregat, Barcelona, Spain, 08908
- Bellvitge Biomedical Research Institute
-
Contact:
- Research Office
- Phone Number: +34932607411
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Presence of mild-to-moderate paresis of the upper extremity after a stroke (having a score between 1 and 4 in the Medical Research Council Scale for Muscle Strength at the distal muscles of the upper extremity);
- More than 6 months post-stroke;
- Completion of formal rehabilitation programs.
Exclusion criteria:
- Major language or cognitive deficits affecting comprehension (Mini-Mental State Examination < 24);
- Neurological or psychiatric co-morbidity;
- Other musculoskeletal condition affecting upper extremity motor function (e.g. fracture or arthritis).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Enriched Music-Supported Therapy group
Participants in the eMST-group will follow a 10-week program of Enriched Music-Supported Therapy.
The program comprises 3 individual self-training sessions and 1 group session per week (total program duration: 40 hours).
|
Home-based rehabilitation program for stroke patients aimed at improving the upper extremity motor function.
The program is based on musical training, combining self-training sessions of music playing using an app for electronic tablets and music therapy group sessions.
Other Names:
|
ACTIVE_COMPARATOR: Control group
Participants in the control intervention group will follow the Graded Repetitive Arm Supplementary Program (GRASP, Harris et al., 2009).
They will be asked to complete 4 weekly one-hour session for 10 weeks (total program duration: 40 hours).
|
Home-based rehabilitation program for stroke patients aimed at improving the upper extremity motor function.
The program comprises self-training sessions of mass repetition of movements and task-specific exercises for the upper extremity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Action Research Arm Test
Time Frame: immediately after the intervention
|
Upper extremity function measure.
The measure is a 19-item test divided into four subtests (grasp, grip, pinch and gross movement).
For each item, the patient is asked to perform a simple task that involves a functional movement of the affected upper limb.
Each task is rated using a 4-point ordinal scale.
The maximum possible score is 57 and the minimal clinically important difference is 5.7 points.
|
immediately after the intervention
|
Change in Action Research Arm Test
Time Frame: 3 months after completing the intervention
|
Upper extremity function measure.
The measure is a 19-item test divided into four subtests (grasp, grip, pinch and gross movement).
For each item, the patient is asked to perform a simple task that involves a functional movement of the affected upper limb.
Each task is rated using a 4-point ordinal scale.
The maximum possible score is 57 and the minimal clinically important difference is 5.7 points.
|
3 months after completing the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: immediately after the intervention
|
Motor impairment measure.
It comprises 33 items that evaluate motor impairment in the affected upper limb.
The test is divided into 4 sections (shoulder, forearm and elbow, wrist, hand and coordination) assessing reflexes, flexor and extensor synergies, range of motion, and overall coordination and speed of the upper extremity.
Each item is graded using an ordinal scale from 0 to 2. The maximum possible score is 66 and the minimal clinically important difference for chronic stroke patients is 5.2 points.
|
immediately after the intervention
|
Change in Fugl-Meyer Assessment of Motor Recovery after Stroke
Time Frame: 3 months after completing the intervention
|
Motor impairment measure.
It comprises 33 items that evaluate motor impairment in the affected upper limb.
The test is divided into 4 sections (shoulder, forearm and elbow, wrist, hand and coordination) assessing reflexes, flexor and extensor synergies, range of motion, and overall coordination and speed of the upper extremity.
Each item is graded using an ordinal scale from 0 to 2. The maximum possible score is 66 and the minimal clinically important difference for chronic stroke patients is 5.2 points.
|
3 months after completing the intervention
|
Change in Grip Strength in Kgs
Time Frame: immediately after the intervention
|
Grip strength measure, Biometrics E-Link tool
|
immediately after the intervention
|
Change in Grip Strength in Kgs
Time Frame: 3 months after completing the intervention
|
Grip strength measure, Biometrics E-Link tool
|
3 months after completing the intervention
|
Change in Box and Block Test
Time Frame: immediately after the intervention
|
Gross manual dexterity measure
|
immediately after the intervention
|
Change in Box and Block Test
Time Frame: 3 months after completing the intervention
|
Gross manual dexterity measure
|
3 months after completing the intervention
|
Change in Nine Hole Pegboard Test
Time Frame: immediately after the intervention
|
Fine manual dexterity measure
|
immediately after the intervention
|
Change in Nine Hole Pegboard Test
Time Frame: 3 months after completing the intervention
|
Fine manual dexterity measure
|
3 months after completing the intervention
|
Change in Chedoke Arm and Hand Activity Inventory
Time Frame: immediately after the intervention
|
Motor performance in activities of daily living measure.
The test is composed of 13 different tasks (i.e.
open a jar of coffee, make a phone call, clean a pair of eyeglasses) and each task is graded using an ordinal scale from 1 to 7. Maximum score is 91, indicating good performance.
|
immediately after the intervention
|
Change in Chedoke Arm and Hand Activity Inventory
Time Frame: 3 months after completing the intervention
|
Motor performance in activities of daily living measure.
The test is composed of 13 different tasks (i.e.
open a jar of coffee, make a phone call, clean a pair of eyeglasses) and each task is graded using an ordinal scale from 1 to 7. Maximum score is 91, indicating good performance.
|
3 months after completing the intervention
|
Change in Behaviour Rating Inventory of Executive Function
Time Frame: immediately after the intervention
|
Executive function measure.
It comprises 75 items describing various behaviours, and the participant is asked to report if the behaviour is never a problem, sometimes a problem or often a problem.
|
immediately after the intervention
|
Change in Behaviour Rating Inventory of Executive Function
Time Frame: 3 months after completing the intervention
|
Executive function measure.
It comprises 75 items describing various behaviours, and the participant is asked to report if the behaviour is never a problem, sometimes a problem or often a problem.
|
3 months after completing the intervention
|
Change in Sustained Attention to Response Task
Time Frame: immediately after the intervention
|
Sustained attention measure
|
immediately after the intervention
|
Change in Sustained Attention to Response Task
Time Frame: 3 months after completing the intervention
|
Sustained attention measure
|
3 months after completing the intervention
|
Change in Figural Memory Subtest
Time Frame: immediately after the intervention
|
Visuospatial memory measure
|
immediately after the intervention
|
Change in Figural Memory Subtest
Time Frame: 3 months after completing the intervention
|
Visuospatial memory measure
|
3 months after completing the intervention
|
Change in Rey Auditory Verbal Learning Test
Time Frame: immediately after the intervention
|
Verbal learning measure
|
immediately after the intervention
|
Change in Rey Auditory Verbal Learning Test
Time Frame: 3 months after completing the intervention
|
Verbal learning measure
|
3 months after completing the intervention
|
Change in Fluency Test
Time Frame: immediately after the intervention
|
Verbal fluency measure
|
immediately after the intervention
|
Change in Fluency Test
Time Frame: 3 months after completing the intervention
|
Verbal fluency measure
|
3 months after completing the intervention
|
Change in Beck Depression Inventory-II
Time Frame: immediately after the intervention
|
Depression measure.
It comprises 21 multiple-choice questions that are scored on a scale from 0 to 3. The participant is asked about feelings, thoughts and behaviours of the past week.
Higher scores indicate depression severity and the maximum possible score of the measure is 63.
|
immediately after the intervention
|
Change in Beck Depression Inventory-II
Time Frame: 3 months after completing the intervention
|
Depression measure.
It comprises 21 multiple-choice questions that are scored on a scale from 0 to 3. The participant is asked about feelings, thoughts and behaviours of the past week.
Higher scores indicate depression severity and the maximum possible score of the measure is 63.
|
3 months after completing the intervention
|
Change in Apathy Evaluation Scale
Time Frame: immediately after the intervention
|
Apathy measure.
The scale comprises a self and informant reports both consisting of 18 items that are scored on a 4-point Likert scale, where higher scores indicate more apathy.
|
immediately after the intervention
|
Change in Apathy Evaluation Scale
Time Frame: 3 months after completing the intervention
|
Apathy measure.
The scale comprises a self and informant reports both consisting of 18 items that are scored on a 4-point Likert scale, where higher scores indicate more apathy.
|
3 months after completing the intervention
|
Change in Profile of Mood States
Time Frame: immediately after the intervention
|
Mood measure.
The measure includes 65 items that are scored on a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely".
|
immediately after the intervention
|
Change in Profile of Mood States
Time Frame: 3 months after completing the intervention
|
Mood measure.
The measure includes 65 items that are scored on a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely".
|
3 months after completing the intervention
|
Change in Stroke Impact Scale
Time Frame: immediately after the intervention
|
Quality of life measure.
It is a 59-item self-report questionnaire that assesses muscle strength, hand function, basic and instrumental activities of daily living, global mobility, communication, emotion, memory and thinking, and participation.
|
immediately after the intervention
|
Change in Stroke Impact Scale
Time Frame: 3 months after completing the intervention
|
Quality of life measure.
It is a 59-item self-report questionnaire that assesses muscle strength, hand function, basic and instrumental activities of daily living, global mobility, communication, emotion, memory and thinking, and participation.
|
3 months after completing the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Self-regulation Questionnaire
Time Frame: Baseline
|
Self-regulation measure.
It evaluates the type of self-regulation (external, interjected, identified or intrinsic) or motivation (external or intrinsic) of the participants to engage with the rehabilitation program.
It is a 15-item self-report questionnaire scored on a 7-point scale (1: not all true; 4: somewhat true; 7: very true).
|
Baseline
|
Treatment Questionnaire Concerning Continued Program
Time Frame: Week 5 (after the first half of the intervention)
|
Self-regulation measure.
It is a 15-item self-report questionnaire scored on a 7-point scale (1: not all true; 4: somewhat true; 7: very true).
|
Week 5 (after the first half of the intervention)
|
Intrinsic Motivation Inventory
Time Frame: immediately after the intervention
|
Motivation measure.
It consists of 24 self-report questions divided into six different psychological constructs reflecting positive or negative predictors of intrinsic motivation: 1) interest/enjoyment; 2) perceived competence; 3) effort/importance; 4) pressure/tension; 5) perceived choice; and 6) value/usefulness.
It is scored on a 7-point scale (1: not all true; 4: somewhat true; 7: very true).
|
immediately after the intervention
|
Strategies Used to Promote Health Questionnaire
Time Frame: Baseline
|
Self-efficacy measure.
It is a 29-item self-report questionnaire that evaluates the degree of self-care and self-efficacy through four factors consistent with the underlying self-efficacy theory upon which the scale is based: 1) coping, 2) stress reduction, 3) making decisions, and 4) enjoying life.
It is scored on a 5-point scale (from 1: very little confidence to 5: quite a lot of confidence).
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Antoni Rodríguez Fornells, PhD, Bellvitge Biomedical Research Institute, University of Barcelona
- Study Director: Jennifer Grau Sánchez, PhD, Bellvitge Biomedical Research Institute, University of Barcelona
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
September 1, 2020
Primary Completion (ANTICIPATED)
July 1, 2021
Study Completion (ANTICIPATED)
July 1, 2022
Study Registration Dates
First Submitted
August 3, 2020
First Submitted That Met QC Criteria
August 7, 2020
First Posted (ACTUAL)
August 11, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 11, 2020
Last Update Submitted That Met QC Criteria
August 7, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201729.30
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Enriched Music-Supported Therapy
-
University of BarcelonaInstitució Catalana de Recerca i Estudis AvançatsUnknown
-
BaycrestCompletedStroke | Upper Extremity ParesisCanada
-
University of Colorado, DenverNational Center for Complementary and Integrative Health (NCCIH)Recruiting
-
Icahn School of Medicine at Mount SinaiRecruitingMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Namik Kemal UniversityEnrolling by invitation
-
Case Comprehensive Cancer CenterCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedAutonomic Nervous System Imbalance | Hypothalamic Pituitary Adrenal Axis SuppressionUnited States
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
Icahn School of Medicine at Mount SinaiCompletedSARS-CoV 2 | Dyspnea | Post Covid-19 RespiratoryUnited States
-
Icahn School of Medicine at Mount SinaiCompleted